Eli Lilly & Co. and Novo Nordisk A/S cut a deal with the Trump administration to lower prices on their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. President Donald Trump spoke about it in the Oval Office.
View Comments
Lilly, Novo Cut Deal to Lower Drug Prices in Exchange for Tariff Relief
Published 1 day ago
Nov 6, 2025 at 5:51 PM
Negative
Auto